COREEN DOMINGO

Concepts (52)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
6
2020
203
0.640
Why?
Vaccines
4
2014
366
0.520
Why?
Doxazosin
2
2020
28
0.310
Why?
Substance-Related Disorders
1
2013
461
0.300
Why?
Dopamine beta-Hydroxylase
2
2018
29
0.250
Why?
Adrenergic alpha-1 Receptor Antagonists
2
2020
19
0.190
Why?
Polymorphism, Genetic
3
2020
818
0.170
Why?
Receptors, Adrenergic, alpha-1
1
2020
18
0.170
Why?
Buprenorphine
1
2019
95
0.140
Why?
Cocaine
3
2014
207
0.140
Why?
Schizophrenic Psychology
1
2016
82
0.120
Why?
Smoking Cessation
1
2016
198
0.110
Why?
Amphetamine-Related Disorders
1
2014
27
0.110
Why?
Drug Design
1
2014
153
0.110
Why?
Cholera Toxin
1
2013
49
0.100
Why?
Immunotherapy
2
2014
681
0.100
Why?
Molecular Targeted Therapy
1
2014
376
0.100
Why?
Stress Disorders, Post-Traumatic
1
2019
627
0.090
Why?
Vaccination
2
2014
962
0.090
Why?
Smoking
1
2016
1051
0.080
Why?
Double-Blind Method
3
2020
1636
0.080
Why?
Pharmacogenetics
2
2020
185
0.070
Why?
Quality of Life
1
2016
1952
0.060
Why?
Humans
10
2022
125757
0.060
Why?
Pilot Projects
2
2020
1398
0.050
Why?
Genotype
2
2020
2569
0.050
Why?
Middle Aged
6
2020
27003
0.050
Why?
Treatment Outcome
4
2019
12425
0.040
Why?
Clinical Trials as Topic
2
2014
1106
0.040
Why?
Receptors, Opioid, kappa
1
2019
23
0.040
Why?
Comparative Effectiveness Research
1
2019
68
0.040
Why?
Narcotic Antagonists
1
2019
109
0.040
Why?
Norepinephrine
1
2018
177
0.040
Why?
Male
6
2020
61813
0.030
Why?
Combined Modality Therapy
1
2020
1249
0.030
Why?
Adult
4
2020
29760
0.030
Why?
Female
6
2020
67035
0.030
Why?
Analgesics, Opioid
1
2019
409
0.030
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2016
213
0.030
Why?
Haptens
1
2014
7
0.030
Why?
Methamphetamine
1
2014
32
0.030
Why?
Safety
1
2014
217
0.030
Why?
Clinical Trials, Phase II as Topic
1
2013
73
0.030
Why?
Antibodies
1
2014
375
0.020
Why?
Research Design
1
2014
695
0.020
Why?
Global Health
1
2014
567
0.020
Why?
Young Adult
2
2014
9119
0.020
Why?
Randomized Controlled Trials as Topic
1
2013
1122
0.020
Why?
Adolescent
2
2014
19477
0.020
Why?
United States
1
2019
10941
0.010
Why?
Animals
2
2014
34392
0.010
Why?
Retrospective Studies
1
2019
16434
0.010
Why?
DOMINGO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (52)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_